ORKAHealthcareMid-Cap
Oruka Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Oruka Therapeutics, Inc. (ORKA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ORKA insiders buying or selling?
Oruka Therapeutics, Inc. insiders reported 24 open-market buys ($5.9M) and 26 sells ($315.6M) across 50 Form 4 filings — a net selling position of $309.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 15, 2026)
Total Form 4 filings
50
SEC EDGAR
Insider filers
12
Insider buys (24)
$5.9M
Insider sells (26)
$315.6M
Insider sentiment
Net sellingNet insider flow of $309.8M in net selling.
Recent ORKA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.0K | $86.28 | $603.9K |
| Jul 13, 2026 | Arjun Agarwal | Senior Vice President, Finance | Sale | 10.0K | $84.63 | $846.2K |
| Jul 2, 2026 | Fairmount Funds Management LLC | Director, 10% Owner | Sale | 3.6M | $84.43 | $300.0M |
| Jul 1, 2026 | Laura Lee Sandler | Chief Operating Officer | Sale | 5.0K | $94.42 | $472.1K |
| Jun 22, 2026 | Arjun Agarwal | Senior Vice President, Finance | Sale | 1.6K | $80.95 | $128.5K |
| Jun 15, 2026 | Arjun Agarwal | Senior Vice President, Finance | Sale | 9.9K | $69.72 | $687.0K |
| Jun 15, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.9K | $69.28 | $550.6K |
| Jun 15, 2026 | Lawrence Otto Klein | Chief Executive Officer | Sale | 1.7K | $69.69 | $120.5K |
| Jun 15, 2026 | Laura Lee Sandler | Chief Operating Officer | Sale | 600 | $69.69 | $41.8K |
| Jun 15, 2026 | Paul T Quinlan | General Counsel | Sale | 733 | $69.69 | $51.1K |
| Jun 12, 2026 | Carl Dambkowski | Director | Sale | 35.0K | $70.13 | $2.5M |
| May 22, 2026 | Carl Dambkowski | Director | Sale | 105.0K | $58.97 | $6.2M |
| May 18, 2026 | Arjun Agarwal | Senior Vice President, Finance | Sale | 10.3K | $59.07 | $607.8K |
| May 16, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.0K | $61.85 | $432.9K |
| May 1, 2026 | Laura Lee Sandler | Chief Operating Officer | Sale | 5.0K | $63.88 | $319.4K |
| Apr 15, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.0K | $66.12 | $462.8K |
| Mar 17, 2026 | Lawrence Otto Klein | Chief Executive Officer | Sale | 1.7K | $41.30 | $71.4K |
| Mar 17, 2026 | Arjun Agarwal | Senior Vice President, Finance | Sale | 395 | $41.30 | $16.3K |
| Mar 17, 2026 | Laura Lee Sandler | Chief Operating Officer | Sale | 600 | $41.30 | $24.8K |
| Mar 17, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.6K | $40.91 | $312.6K |
| Mar 17, 2026 | Paul T Quinlan | General Counsel | Sale | 733 | $41.30 | $30.3K |
| Mar 2, 2026 | Laura Lee Sandler | Chief Operating Officer | Sale | 5.0K | $33.56 | $167.8K |
| Feb 17, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.0K | $32.37 | $226.6K |
| Jan 16, 2026 | Joana Goncalves | Chief Medical Officer | Sale | 7.0K | $31.81 | $222.7K |
| Jan 3, 2026 | Laura Lee Sandler | Chief Operating Officer | Sale | 13.0K | $28.52 | $370.8K |
Showing the 25 most recent of 50 Form 4 filings for Oruka Therapeutics, Inc..
Most active ORKA insiders
- Funicular Fund, LP13 filings
- Joana Goncalves8 filings
- Laura Lee Sandler6 filings
- Robert E Conway6 filings
- Arjun Agarwal5 filings
Ask anything about ORKA insider activity
Use Trabud's AI agent to query Oruka Therapeutics, Inc.'s Form 4 history in plain English — "Show me ORKA CEO purchases this year" or compare it against any other ticker.
Open the AI agentORKA insider trading FAQ
Are Oruka Therapeutics, Inc. insiders buying or selling?
Across 50 SEC Form 4 filings, Oruka Therapeutics, Inc. (ORKA) insiders reported 24 open-market purchases totaling $5.9M and 26 sales totaling $315.6M. That is a net selling position of $309.8M.
How many insiders trade ORKA stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Oruka Therapeutics, Inc.. The most recent filing was accepted on Jul 15, 2026.
Where does Trabud get ORKA insider trading data?
All ORKA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.